Knock Out Sarcoma

Dear Knock Out Sarcoma Participants and Supporters,

Thanks so much to everyone who showed up and joined us in person for the Van Cortlandt Park run last year. We couldn't have had better weather and the event proved to be educational, meaningful and phenomenally successful! We also want to thank and recognize all of our virtual participants, donors, and industry sponsors who helped make the event so special.

We would like to send a special thanks to our 2022 sponsors, old and new - and look forward to having their ongoing support in a year for our 6th annual event!!

Thanks to all of you we were able to exceed prior fundraising results! These funds are so essential for novel and exploratory research projects.  They were instrumental in helping Dr. Hoang realize NIH grant support! They will hopefully yield better solutions and treatments for sarcoma patients both here at Montefiore and beyond.

We are starting to plan our 2023 event and hope to see everyone back again for another outstanding fun run! This year, we will again have an educational session for all the health care providers, residents, interns, medical students, physician extenders, and staff members - many of whom do so much for our patients each and every day. We will also extend warm invitations to many of our patients, their families, and their friends. Finally, we hope many of our larger network or colleagues, co-workers, and connections will come out for a good cause and a great event! Please save the date, keep us in mind, and help us knock out sarcoma!!


Sincerely,

David S. Geller, MD


Sarcomas are rare and your support can make a big difference! Join in the fight and help support our efforts!


Sarcomas are a rare form of cancer, affecting patients of all ages. Many of these sarcomas arise in otherwise healthy children and young adults and inflict a tremendous toll on both the patient and their family. The Division of Orthopedic Oncology at Montefiore Medical Center is dedicated to the diagnosis and treatment of patients with both soft-tissue and bone sarcomas. In addition, our laboratory seeks to better understand how these tumors arise and in turn, how to better treat them.